Clinical Trial Update: FOSAMAX PLUS and FOSAMAX PLUS D Re-examination Study (0217A-267)

View source ↗

Summary

A re-examination study update for FOSAMAX PLUS and FOSAMAX PLUS D in osteoporosis with completed status and results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Fosamax Plus (alendronate sodium / cholecalciferol)
• Fosamax Plus D (Alendronate Sodium and Cholecalciferol)

Snippet

Sponsor: Organon and Co | Conditions: Osteoporosis | Status: COMPLETED | Results posted: 2011-09-13